covid-19

Covid-19: Oxford-AstraZeneca Vaccine Approve for use in UK

- ADVERTISEMENT -

Covid-19 vaccine, AstraZeneca vaccine has been approved for use in the UK, with the first doses due to be given on Monday. However, there will be 530,00 doses available from next week.  The vaccination centers will now begin to invite patients to come and get the vaccine.

covid-19

The United Kingdom has ordered 100 million Covid-19 vaccines, enough to vaccinate 50 million people. It comes as millions more in England are placed in tier four restrictions.

- ADVERTISEMENT -

Meanwhile, all over 50s and younger adults with health conditions will be offered jab in the first phase of the rollout. It is hoped that about two million patients a week could soon be vaccinated with two vaccines now approved.

The Covid-19 vaccine is easier to store and give out, as it can be kept at normal fridge temperate unlike Pfizer-BioNtech jab that has to be preserved at 70C

The immunization campaign will now shift to giving as many people as possible their first dose of vaccine with a second dose following within that period.

Meanwhile, the Pfizer/BioNTech Covid-19 vaccine cal now be given to people with a wide range of food and medicine allergies. But people allergic to ingredients in the Covid-19 vaccine should not be allowed to take it. Either of the Covid-19 vaccines can now be administered to Pregnant women and also Breastfeeding women

Covid-19: No Corners Cut

The United Kingdom’s National Health Service is increasing pressure as Covid-19 cases soar in many parts of the states. The UK has recorded new Covid-19 cases of 53,135. Breaking its daily record since the pandemic started for the second day in a row.

However, more areas of England moved into the toughest level of restrictions. attempts to limit the spread of the new, more infectious variant.

The Oxford/AstraZeneca Covid-19 vaccine can be kept in the refrigerator temperature of 2 to 8 degrees for at most six months. Trials have shown two full doses of the Pfizer-BioNtech Jab were 95% effective at preventing infection. Hence the Oxford-AstraZeneca vaccine showed 62% effectiveness.

The good news is Oxford-AstraZeneca vaccine has also shown that when people were given a half dose, effectiveness hit 90%. Although, there was not enough clear data to approve the half-dose, full dose idea. All the vaccines are expected to be equally effective against the new variants of the virus that have appeared.

- ADVERTISEMENT -

Meanwhile, Magaret Keenan became the first person in the world to be given a Covid vaccine outside a clinical trial.

Facebook Comments
If you have a story you want to tell, send it to Cinema9ja Ent. via [email protected]